
-
Vigil Neuroscience NASDAQ:VIGL
Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-1.308M
Cash
97.8M
Avg Qtr Burn
-12.81M
Short % of Float
1.51%
Insider Ownership
18.13%
Institutional Own.
68.32%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Iluzanebart (VGL101) Details Adult onset leukoencephalopathy w/ axonal spheroids & pigmented glia | Phase 2 Data readout | |
VG-3927 Details Alzheimer's disease | Phase 2 Initiation |